ProteanTecs

ProteanTecs was founded in 2017 by Shai Cohen (CEO), Evelyn Landman (CTO), and Roni Ashuri, all of whom were previously co-founders or senior executives at Mellanox Technologies. The company is headquartered in Haifa, Israel, with additional offices in the US, Taiwan, and India. It operates as a private company and has raised over $190 million in total funding as of its late 2022 Series C extension, backed by investors including Koch Disruptive Technologies, Valor Equity Partners, and Porsche SE. The core product is a cloud-based analytics platform that monitors the health, performance, and reliability of complex semiconductors using embedded on-chip agents.

The company's primary technology is Universal Chip Telemetry (UCT). ProteanTecs integrates proprietary monitoring agents directly into the silicon design of advanced system-on-chips (SoCs). Once the chip is manufactured, these agents transmit continuous telemetry data to a cloud-based machine learning platform. This solves the problem of detecting latent manufacturing defects, predicting in-field chip failures, and optimizing power and performance for advanced node electronics. The buyers are primarily fabless semiconductor companies, datacenter operators, and automotive OEMs.

ProteanTecs competes in the Silicon Lifecycle Management (SLM) category. Direct competitors include the SLM division of Synopsys and PDF Solutions. The company operates as an ecosystem partner within the semiconductor supply chain, maintaining official partnerships with foundries like TSMC and automated test equipment (ATE) providers like Advantest.

The company's global headquarters and main R&D center are located in Haifa. The founding and executive teams are predominantly Israeli, drawing heavily from the local semiconductor and networking talent pool established by companies like Mellanox and Intel. Engineering hiring in Israel focuses on VLSI design, machine learning, data science, and cloud backend infrastructure.